MDS-NMS TRANSLATION PROGRAM

MDS-NMS TRANSLATION PROGRAM FOR NON-ENGLISH OFFICIAL VERSIONS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030220360

Enrollment

300

Registered

2022-10-05

Start date

2022-06-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

parkinson's disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients whose native language is Japanese Patients diagnosed with Parkinson's disease according to the International Parkinson and Movement Disorder Society's Parkinson's Disease Diagnostic Criteria 2015 Patients who are able to obtain written consent for participation in the study of their own free will after receiving a thorough explanation of their participation in the study. Patients between the ages of 20 and 79 years old Any gender

Exclusion criteria

Exclusion criteria: Patients with serious underlying diseases or complications that make it difficult for the attending physician to make an evaluation decision. Other patients who are deemed inappropriate as research subjects by the principal investigator.

Design outcomes

Primary

Measure	Time frame
Confirmatory factors for the 9 domains of MDS-NMS	—

Contacts

Public ContactMatsuzaki Yoshiyuki

Mebix Inc.

MDS-NMS_validation-study@mebix.co.jp+81-3-4362-4500

Outcome results